6 - 10 of 649
May 4, 2020

Successful Installation of World’s First 1.2 GHz NMR System Enables Novel Functional Structural Biology Research

CERM of University of Florence, Italy Accepts Bruker 1.2 GHz NMR System

April 30, 2020

Bruker Pharma Newsletter

In the focus: NMR under GxP in Drug Development and Manufacturing, The Use of Positron Emission Tomography-Computed Tomography (PET/CT) to Assist Preclinical Oncology Research, Routine DAR Analysis, Online Fermentation Monitoring with FT-NIR Spectroscopy.

April 20, 2020

FIRST Newsletter - April 2020

In this issue: Launch of the new S2 PUMA Series 2, C and S determination in cement with G4 ICARUS Series 2, getting the most from your SC-XRD instrument during COVID-19 lockdown, EIGER2 R 500K upgrades for D8 ADVANCE and D8 DISCOVER, lubricating oils by ASTM D6481 with S2 POLAR, pharmaceutical structure solution from powder diffraction data, quality control of limestone with S6 JAGUAR, G4 ICARUS Series 2 determination of C and S in limestone and dolomite, Bruker-MIT Symposium 2020 report, and flat-field corrections in micro-CT scan setups.

April 11, 2020

Bruker partners with ANPC to support major new frontline response to combat the COVID-19 threat

Bruker is proud to partner with Australian National Phenome Centre (ANPC) at Murdoch University to support the work of their researchers into the COVID-19 pandemic threat.

April 1, 2020

Bruker Highlights New Analytical Systems and Applied Market Solutions

BILLERICA, Massachusetts – April 1, 2020 – Bruker Corporation (Nasdaq: BRKR) this week highlights new analytical systems and high-value solutions for biopharma and forensics applications, as well as for industrial process control and materials science research. Originally, Bruker had planned to launch these products at Analytica 2020 this week. However, with conferences and tradeshows postponed or cancelled due to COVID-19, Bruker remains committed to the success of its customers, and is proceeding with on-line launches at this time.